1.	Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases Phase: Phase II Type: Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2010-01292, ACRIN 6687, CDR0000647592, U01CA080098, NCT00936975
2.	Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer Phase: No phase specified Type: Diagnostic Status: Closed Age: Not specified Sponsor: NCI Protocol IDs: NCI-2011-02972, 09-364, CDR0000666327, MGH-09364, NCT00956163
3.	Prospective Study of Whole-Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole-Body MRI for the Detection of Bone Metastases in Patients With Prostate Cancer Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MGH-09364, 09-364, 8336
4.	Imaging in MGUS, SMM and MM Phase: No phase specified Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: 110020, 11-C-0020, NCT01237054
5.	F-18 Sodium Fluoride in Prostate Cancer Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: 110021, 11-C-0021, NCT01240551